Ausgabe 2/2011
Inhalt (15 Artikel)
Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model
- Review
Wim Maes, Stefaan W. Van Gool
Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909
- Open Access
- Original Article
Jürgen Kuball, Karin de Boer, Eva Wagner, Mohammed Wattad, Edite Antunes, Risini D. Weeratna, Alain P. Vicari, Carina Lotz, Suzanne van Dorp, Samantha Hol, Philip D. Greenberg, Wolfgang Heit, Heather L. Davis, Matthias Theobald
Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy
- Original Article
Matthias Wölfl, Katharina Merker, Henner Morbach, Stefaan W. Van Gool, Matthias Eyrich, Philip D. Greenberg, Paul G. Schlegel
Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis
- Original Article
Richard J. Warrington, Keith E. Lewis
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination
- Original Article
Matteo Vergati, Vittore Cereda, Ravi A. Madan, James L. Gulley, Ngar-Yee Huen, Connie J. Rogers, Kenneth W. Hance, Philip M. Arlen, Jeffrey Schlom, Kwong Y. Tsang
Migration and immunological reaction after the administration of αGalCer-pulsed antigen-presenting cells into the submucosa of patients with head and neck cancer
- Original Article
Motoyoshi Kurosaki, Shigetoshi Horiguchi, Kazuki Yamasaki, Yoshitaka Uchida, Shinichiro Motohashi, Toshinori Nakayama, Akira Sugimoto, Yoshitaka Okamoto
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
- Original Article
Salomé González-Reyes, Jesús M. Fernández, Luis O. González, Alina Aguirre, Aurelio Suárez, José M. González, Safwan Escaff, Francisco J. Vizoso
Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors
- Open Access
- Original Article
Rikke Sick Andersen, Rikke Bæk Sørensen, Cathrin Ritter, Inge Marie Svane, Jürgen C. Becker, Per thor Straten, Mads Hald Andersen
IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype
- Original Article
Jana Albrecht, Michaela Frey, Daniel Teschner, Alexander Carbol, Matthias Theobald, Wolfgang Herr, Eva Distler
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
- Original Article
W. Joost Lesterhuis, Gerty Schreibelt, Nicole M. Scharenborg, H. Mary-lène H. Brouwer, Marie-Jeanne P. Gerritsen, Sandra Croockewit, Pierre G. Coulie, Ruurd Torensma, Gosse J. Adema, Carl G. Figdor, I. Jolanda M. de Vries, Cornelis J. A. Punt
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings
- Original Article
Stéphane Oudard, Olivier Rixe, Benoit Beuselinck, Claude Linassier, Eugeniu Banu, Jean-Pascal Machiels, Marion Baudard, François Ringeisen, Thierry Velu, Marie-Aude Lefrere-Belda, Jean-Marc Limacher, W. H. Fridman, Michel Azizi, Bruce Acres, Eric Tartour
Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery
- Original Article
Gregory Driessens, Lise Nuttin, Alain Gras, Julie Maetens, Stephane Mievis, Marylène Schoore, Thierry Velu, Liliane Tenenbaum, Véronique Préat, Catherine Bruyns
CDR2 antigen and Yo antibodies
- Open Access
- Original Article
Cecilie Totland, Nina K. Aarskog, Tilo W. Eichler, Mette Haugen, Jane K. Nøstbakken, Sissel E. Monstad, Helga B. Salvesen, Sverre Mørk, Bjørn I. Haukanes, Christian A. Vedeler
CD8 Co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β (TGF-β)-mediated suppression
- Short Communication
Andrew Zloza, Michael C. Jagoda, Gretchen E. Lyons, Michael C. Graves, Frederick J. Kohlhapp, Jeremy A. O’Sullivan, Andrew T. Lacek, Michael I. Nishimura, José A. Guevara-Patiño
“Tumor immunology meets oncology (TIMO) VI” from 7th to 8th of May 2010 in Halle, Germany
- Meeting Report
Dagmar Quandt, Chiara Massa, Barbara Seliger
